glp-1 and lupus The anti-inflammatory immunological properties of Receptor Agonists Exploring GLP-1 Agonists for Autoimmune

Unfortunately, the surge in use of these drugs has also translated into a huge increase in accidental overdoses

Why it matters: Poor planning leads to poor choices, missed protein targets, and increased side effects from unsuitable foods

Peak weight loss on GLP-1 medications usually hits around the one-year mark, so this means most patients need to think in terms of 18 months or so from starting therapy to being ready for cosmetic facial work

Human Trials That Could Advance Practice in the Near-Term Beyond the trials in progress listed at the bottom of this article, there are a number of study questions which we believe could rapidly advance our knowledge for important use cases in the near to mid-term and bring GLP-1s into the clinic faster